查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1735840

全球大麻 CBD 市场规模研究（按最终用途、配销通路和区域预测，2022-2032 年）

Global Hemp CBD Market Size study, by End Use, Distribution Channel, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球大麻 CBD 市场价值约为 39.1 亿美元，预计在 2024-2032 年预测期内将以超过 18.59% 的惊人复合年增长率增长。大麻二酚 (CBD) 是一种从大麻中提取的非精神活性化合物，已成为健康、製药和营养保健品市场中最具颠覆性和变革性的力量之一。其受欢迎程度的飙升可以归因于其广泛的治疗益处——从疼痛管理和抗炎特性到治疗焦虑和失眠的功效——使其成为多个消费者群体青睐的替代品。随着监管环境的变化和社会对大麻衍生物态度的缓和，大麻衍生的 CBD 产品已在主流零售通路站稳脚跟，推动了已开发经济体和新兴经济体的需求。

大麻 CBD 市场的上升势头因多种宏观经济和行为变化的共同作用而得到加强。随着人们对植物疗法益处的认识不断提高，加上对自然健康疗法的倾向不断增强，消费者的兴趣也日益浓厚。此外，各司法管辖区内大麻种植的合法化刺激了供应链，为酊剂、外用药、食品和个人护理用品等产品类别的创新打开了闸门。然而，市场仍在努力应对诸如监管框架不一致、缺乏标准化剂量方案以及品质控制挑战等复杂问题。即便如此，製造商、研究机构和政府机构之间不断增加的研发投入和策略合作正在积极解决这些障碍，为可扩展、合规的成长铺平道路。

消费者的偏好变得越来越复杂，促使品牌提供多样化的产品并增强交付方式。从水溶性 CBD 饮料到吸收率更快的奈米乳化配方，创新竞赛正在重新定义该领域的竞争优势。此外，人们越来越注重功能性健康，注入 CBD 的产品现在已融入日常生活，例如皮肤护理、营养补充，甚至宠物护理。分销管道也同步发展，电子商务平台在扩大覆盖范围方面发挥关键作用，而药房、保健品商店和专卖店等实体店则透过店内教育和产品试用来增强消费者信任。

由于早期监管自由化、消费者意识高以及供应链基础设施完善，北美在全球大麻 CBD 市场占据主导地位。在新创公司、传统健康品牌和积极的营销活动的推动下，美国继续在创新和采用方面处于领先地位。欧洲紧随其后，成为有力的竞争者，得益于其註重健康的民众、不断进步的监管变化以及替代药物支出的增加。亚太地区虽然相对新兴，但由于合法化框架的扩大、可支配收入的增加以及中国、印度和日本等主要市场的消费者生活方式的改变，该地区正在经历加速成长。拉丁美洲和中东及非洲正逐渐成为一个机会丰富的地区，特别是随着政府启动大麻改革和健康意识的提高。

目录

第一章：全球工业大麻 CBD 市场执行摘要

  • 全球市场规模及预测（2022-2032）
  • 区域概要
  • 分段总结
    • 按最终用途
    • 按配销通路
  • 主要趋势
  • 经济衰退的影响
  • 分析师建议与结论

第二章：全球大麻CBD市场定义与研究假设

  • 研究目标
  • 市场定义
  • 研究假设
    • 包容与排斥
    • 限制
    • 供给侧分析
      • 种植和提取能力
      • 处理基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（生产者视角）
    • 需求面分析
      • 监理框架
      • 消费者认知与接受度
      • 配方技术进步
      • 健康与保健趋势
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第三章：全球大麻CBD市场动态

  • 市场驱动因素
    • 扩大治疗应用与健康应用
    • 大麻种植的合法化与管制自由化
    • 对天然植物性健康解决方案的需求激增
  • 市场挑战
    • 不同地区的监管框架不一致
    • 品质控制和缺乏标准化剂量
    • 供应链复杂性和原料多变性
  • 市场机会
    • 递送形式的创新（奈米乳液、水溶性混合物）
    • 电子商务和直接面向消费者的管道扩张
    • 新兴市场的成长潜力

第四章：全球大麻CBD市场产业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手
    • 波特五力模型的未来主义方法
    • 五力影响分析
  • PESTEL分析
    • 政治的
    • 经济的
    • 社会的
    • 科技
    • 环境的
    • 合法的
  • 最佳投资机会
  • 最佳获胜策略
  • 颠覆性趋势
  • 产业专家观点
  • 分析师建议与结论

第五章：全球大麻 CBD 市场规模及预测：依最终用途划分，2022 年至 2032 年

  • 细分仪表板
  • 2022 年和 2032 年按最终用途分類的收入趋势分析（百万美元/十亿美元）
    • 个人使用
    • 医疗用途
    • 健康与化妆品
    • 食品和饮料
    • 其他的

第六章：全球大麻 CBD 市场规模及预测：依配销通路划分，2022-2032 年

  • 细分仪表板
  • 2022 年和 2032 年按配销通路分類的收入趋势分析（百万美元/十亿美元）
    • 在线的
    • 离线

第七章：全球大麻 CBD 市场规模及预测：按地区划分，2022-2032 年

  • 北美洲
    • 我们
      • 依最终用途细分，2022-2032 年
      • 按配销通路细分，2022-2032 年
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 8 章：竞争情报

  • 重点公司 SWOT 分析
    • Charlotte's Web Holdings, Inc.
    • Aurora Cannabis Inc.
    • Canopy Growth Corporation
  • 顶级市场策略
  • 公司简介
    • Charlotte's Web Holdings, Inc.
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • Aurora Cannabis Inc.
    • Canopy Growth Corporation
    • CV Sciences, Inc.
    • Elixinol Global Limited
    • Medical Marijuana, Inc.
    • HempMeds
    • Endoca
    • Joy Organics
    • Green Roads
    • CBDistillery
    • Medterra CBD
    • NuLeaf Naturals, LLC
    • Veritas Farms, Inc.
    • PharmaHemp doo

第九章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
简介目录

Global Hemp CBD Market is valued approximately at USD 3.91 billion in 2023 and is anticipated to grow with an impressive CAGR of more than 18.59% over the forecast period 2024-2032. Cannabidiol (CBD), a non-psychoactive compound derived from hemp, has emerged as one of the most disruptive and transformative forces in the wellness, pharmaceutical, and nutraceutical markets. Its surge in popularity can be traced to its wide-ranging therapeutic benefits-ranging from pain management and anti-inflammatory properties to its efficacy in treating anxiety and insomnia-making it a favored alternative across multiple consumer demographics. As regulatory landscapes evolve and societal attitudes toward cannabis derivatives soften, hemp-derived CBD products have secured a foothold across mainstream retail channels, driving demand across both developed and emerging economies.

The upward momentum in the hemp CBD market has been reinforced by several converging macroeconomic and behavioral shifts. Increasing awareness regarding the benefits of plant-based therapies, coupled with a rising inclination toward natural health remedies, has amplified consumer interest. Moreover, the legalization of hemp cultivation in various jurisdictions has galvanized the supply chain and opened floodgates for innovation across product categories including tinctures, topicals, edibles, and personal care items. However, the market continues to wrestle with complexities such as inconsistent regulatory frameworks, lack of standardized dosing protocols, and quality control challenges. Even so, increasing R&D investments and strategic collaborations among manufacturers, research institutions, and government bodies are actively addressing these barriers, paving the way for scalable, compliant growth.

Consumer preferences are becoming more sophisticated, pushing brands to diversify their product offerings and enhance delivery formats. From water-soluble CBD beverages to nano-emulsified formulations with faster absorption rates, the innovation race is redefining competitive advantage in this space. Additionally, there is a marked shift toward functional wellness, with CBD-infused products now integrated into daily routines such as skincare regimens, nutritional supplementation, and even pet care. Distribution channels have evolved in tandem, with e-commerce platforms playing a pivotal role in expanding reach, while brick-and-mortar outlets like pharmacies, wellness stores, and specialty boutiques are bolstering consumer trust through in-store education and product sampling.

North America dominates the global hemp CBD market, owing to early regulatory liberalization, high consumer awareness, and a well-established supply chain infrastructure. The United States continues to lead in innovation and adoption, spurred by a robust ecosystem of startups, legacy health brands, and aggressive marketing campaigns. Europe follows as a close contender, supported by a health-conscious population, progressive regulatory changes, and increased spending on alternative medicine. Asia Pacific, though relatively nascent, is witnessing accelerating growth due to expanding legalization frameworks, rising disposable income, and evolving consumer lifestyles in key markets like China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as opportunity-rich zones, particularly as governments initiate cannabis reform and health & wellness awareness improves.

Major market player included in this report are:

  • Charlotte's Web Holdings, Inc.
  • Aurora Cannabis Inc.
  • Canopy Growth Corporation
  • CV Sciences, Inc.
  • Elixinol Global Limited
  • Medical Marijuana, Inc.
  • HempMeds
  • Endoca
  • Joy Organics
  • Green Roads
  • CBDistillery
  • Medterra CBD
  • NuLeaf Naturals, LLC
  • Veritas Farms, Inc.
  • PharmaHemp d.o.o.

The detailed segments and sub-segment of the market are explained below:

By End Use

  • Personal Use
  • Medical Use
  • Wellness and Cosmetics
  • Food and Beverage
  • Others

By Distribution Channel

  • Online
  • Offline

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical Year - 2022
  • Base Year - 2023
  • Forecast Period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Hemp CBD Market Executive Summary

  • 1.1. Global Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By End Use
    • 1.3.2. By Distribution Channel
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Hemp CBD Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply-Side Analysis
      • 2.3.3.1. Cultivation & Extraction Capacity
      • 2.3.3.2. Processing Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Producer Perspective)
    • 2.3.4. Demand-Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Consumer Awareness & Acceptance
      • 2.3.4.3. Technological Advancements in Formulation
      • 2.3.4.4. Health & Wellness Trends
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Hemp CBD Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Widening therapeutic applications and wellness adoption
    • 3.1.2. Legalization and regulatory liberalization of hemp cultivation
    • 3.1.3. Surge in demand for natural, plant-based health solutions
  • 3.2. Market Challenges
    • 3.2.1. Inconsistent regulatory frameworks across regions
    • 3.2.2. Quality control and lack of standardized dosing
    • 3.2.3. Supply chain complexities and raw material variability
  • 3.3. Market Opportunities
    • 3.3.1. Innovation in delivery formats (nano-emulsions, water-soluble blends)
    • 3.3.2. E-commerce and direct-to-consumer channel expansion
    • 3.3.3. Growth potential in emerging markets

Chapter 4. Global Hemp CBD Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Five Forces
    • 4.1.7. Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Hemp CBD Market Size & Forecasts by End Use, 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Revenue Trend Analysis by End Use, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Personal Use
    • 5.2.2. Medical Use
    • 5.2.3. Wellness and Cosmetics
    • 5.2.4. Food and Beverage
    • 5.2.5. Others

Chapter 6. Global Hemp CBD Market Size & Forecasts by Distribution Channel, 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Revenue Trend Analysis by Distribution Channel, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. Online
    • 6.2.2. Offline

Chapter 7. Global Hemp CBD Market Size & Forecasts by Region, 2022-2032

  • 7.1. North America
    • 7.1.1. U.S.
      • 7.1.1.1. By End Use breakdown, 2022-2032
      • 7.1.1.2. By Distribution Channel breakdown, 2022-2032
    • 7.1.2. Canada
  • 7.2. Europe
    • 7.2.1. UK
    • 7.2.2. Germany
    • 7.2.3. France
    • 7.2.4. Spain
    • 7.2.5. Italy
    • 7.2.6. Rest of Europe
  • 7.3. Asia Pacific
    • 7.3.1. China
    • 7.3.2. India
    • 7.3.3. Japan
    • 7.3.4. Australia
    • 7.3.5. South Korea
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Latin America
    • 7.4.1. Brazil
    • 7.4.2. Mexico
    • 7.4.3. Rest of Latin America
  • 7.5. Middle East & Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. South Africa
    • 7.5.3. Rest of Middle East & Africa

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Charlotte's Web Holdings, Inc.
    • 8.1.2. Aurora Cannabis Inc.
    • 8.1.3. Canopy Growth Corporation
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Charlotte's Web Holdings, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Aurora Cannabis Inc.
    • 8.3.3. Canopy Growth Corporation
    • 8.3.4. CV Sciences, Inc.
    • 8.3.5. Elixinol Global Limited
    • 8.3.6. Medical Marijuana, Inc.
    • 8.3.7. HempMeds
    • 8.3.8. Endoca
    • 8.3.9. Joy Organics
    • 8.3.10. Green Roads
    • 8.3.11. CBDistillery
    • 8.3.12. Medterra CBD
    • 8.3.13. NuLeaf Naturals, LLC
    • 8.3.14. Veritas Farms, Inc.
    • 8.3.15. PharmaHemp d.o.o.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
OSZAR »